AI Market Cap Pro
← Back to Scanner Pricing
📅 Next earnings: October 29, 2026

ResMed Inc. (RMD) — Pre-Earnings Stock Analysis

Healthcare, Medical Instruments & Supplies

$236.26
Current Price
$33.2B
Market Cap
22.7
Trailing P/E
$250
Analyst Target
17
Analysts
Buy
Rating

🔥 Get RMD Targets Before Earnings

Pre-earnings entry zone, analyst PE target, 3-day and 5-day implied move, and stop loss — all unlocked with a $5/month subscription.

Unlock Full Analysis →

About ResMed Inc. (RMD)

ResMed Inc. trades on NASDAQ under the ticker RMD. The company operates in the Healthcare sector — specifically Medical Instruments & Supplies.

Current analyst consensus rating: Buy with a $250 price target based on 17 analyst opinions.

EPS (trailing): $10.43  |  Market Cap: $33.2B

Healthcare Medical Instruments & Supplies

Pre-Earnings Trading Strategy for RMD

Trading stocks before earnings requires understanding three key variables: the implied move (what the options market expects), the historical beat rate for the sector, and the current momentum leading into the report.

For RMD, the next earnings report is scheduled for October 29, 2026.

The implied move is calculated using at-the-money straddles — if the straddle is priced at X%, the market is pricing in approximately a ±X% move in either direction around the earnings release.

How AI Market Cap Finds Pre-Earnings Setups

Our pre-earnings momentum scanner scores RMD across five factors to identify high-conviction setups:

The Pro subscription shows the full target range, stop loss, and implied move for RMD and all 20+ stocks in the current earnings window.